6 January 2025
Gelion plc
("Gelion" or "the
Company")
Director appointment - Dr
Graham Cooley
Further to the announcement made on
18 December 2024, the Board of Gelion plc, the global energy
storage innovator, is pleased to announce the appointment of Dr
Graham Cooley, as Non-Executive Director of the Company with
immediate effect. Dr Cooley's appointment strengthens the Company's
capabilities and corporate governance for the next stage of its
growth.
Dr Graham Cooley brings a wealth of
relevant experience and knowledge to the Gelion Board through his
background in the power, energy storage and hydrogen sectors over
more than 35 years. He was previously Business Development Manager
at National Power plc, the UK's largest power generator, and CEO of
ITM Power plc, the first hydrogen related company quoted on AIM. Dr
Cooley has been involved in a wide range of corporate transactions,
including ones that have raised over £600m for UK cleantech SMEs.
He also has a track record of forging industrial partnerships and
entering new markets. He has been an active investor in AIM UK
cleantech companies for over a decade and holds a PhD in Materials
Physics, an MBA and has several fellowship appointments.
Dr Cooley has been appointed as a
member of the Company's Audit Committee and Remuneration
Committee.
Steve Mahon, Chairman of Gelion, commented:
"I am delighted to be welcoming Graham to the
Gelion board. He brings extensive and very relevant experience
which will prove invaluable as we continue to progress toward
commercialisation of our battery technologies."
John Wood, Chief Executive of Gelion, commented:
"Graham brings his exemplary full scope
entrepreneurial perspective to the Gelion board, with the
combination of the depth of personal understanding he has of
delivering successful commercialisation and value development
running innovation companies, along with his experience with
investment markets. Welcome Graham!"
Further disclosures pursuant to Rule 17 and Schedule Two,
paragraph (g) of the AIM Rules for Companies:
Dr
Graham Edward Cooley
The following information regarding
the appointment of Dr Graham Edward Cooley, aged 61, is disclosed
under Schedule 2(g) of the AIM Rules for Companies:
|
Current directorships and/or partnerships
|
Past
directorships and/or partnerships (within the last five
years)
|
|
Light Science Technologies Holdings
plc
|
ITM Power plc
|
|
Brigantia Capital Ltd
|
H2 Green Ltd
|
|
Cadent Gas Limited
|
ITM Power UK Limited (formerly ITM
Power (Trading) Limited)
|
|
Cap-XX Limited
|
ITM Power Pty Limited
|
|
Quadgas Holdco Limited
|
ITM Linde Electrolysis
GmbH
|
|
Quadgas Investments Bidco
Limited
|
ITM Power ApS
|
|
Quadgas Midco Limited
|
ITM Power Service GmbH
|
|
Quadgas Pledgeco Limited
|
ITM Service GmbH
|
|
Yelooc Limited
|
ITM Power (Shelfco)
Limited
|
|
LSTH Trustee Limited
|
ITM Power (Research)
Limited
|
|
Light Science Technologies
Ltd
|
Motive Fuels Limited
|
|
Tomtech (UK) Limited
|
Nanosun Limited
|
|
LSTH IFB Limited
|
Orkney Hydrogen Trading
Ltd
|
|
UK Circuits and Electronics Solutions
Limited
|
Renewable UK Association
|
|
UK Circuits and Electronics Solutions
Holdings Limited
|
|
|
Quadgas Holdings Topco Limited
(UK)
|
|
|
Quadgas Holdings Topco Limited
(Jersey)
|
|
Nanosun Limited entered into director
led administration on 6 February 2024 and on the same date, a
pre-pack sale of the business and certain assets was
completed.
Dr Cooley currently holds 666,666
Ordinary Shares, representing 0.45% of the Company's issued
Ordinary Share capital.
CONTACTS
|
Gelion plc
John Wood, CEO
Amit Gupta, CFO
|
via
Alma
|
|
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)
|
+44
20 7220 0500
|
|
Neil McDonald / Seamus Fricker /
Adam Rae (Corporate Finance)
Louise Talbot (Sales)
|
|
|
Oberon Capital (Joint
Broker)
|
+44
20 3179 5300
|
|
Nick Lovering, Mike Seabrook, Adam
Pollock
|
|
|
Alma Strategic Communications (Financial PR Adviser)
Justine James / Hannah Campbell /
Will Ellis Hancock
|
+44
20 3405 0205
gelion@almastrategic.com
|
About Gelion
Gelion ("gel: ion") is a global
energy storage innovator, supporting the transition to a more
sustainable economy by commercialising two globally important next
generation technologies: Lithium-Sulfur (LiS) and Zinc-based (Zn)
hybrid cells to electrify mobile and stationary applications.
Gelion plc (the Group) is listed on the London Stock Exchange's
Alternative Investment Market and wholly owns Australia based
Gelion Technologies Pty Ltd and UK based OXLiD Ltd. Gelion is
designing and delivering innovative battery technologies and
integrated systems solutions to enable that transition and return
value for its customers and investors.
